Results 51 to 60 of about 3,636 (153)

Flock-Level Seroprevalence against Avian Pneumovirus amongst Uruguayan Broiler Chickens [PDF]

open access: yesInternational Journal of Poultry Science, 2010
The objective of this study was to estimate the true prevalence of seropositive broiler chickens against avian pneumovirus at flock-level in Uruguay, using the Rogan-Gladen estimator in conjunction with Bayesian inference. A total of 181 pooled samples (consisting of 10 individual-chicken sera each) from the study area were examined with the enzyme ...
Giossa, G.   +5 more
openaire   +2 more sources

From Bat to Worse: The Pivotal Role of Bats for Viral Zoonosis

open access: yesMicrobial Biotechnology, Volume 18, Issue 7, July 2025.
Thanks to a dampened inflammatory innate immune response, various Chiropteran (bat) species frequently carry ‐ without showing symptoms – diverse viruses that can cause severe diseases in humans. The reasons why bats are a pivotal virus reservoir for emerging viral diseases are discussed in this Lilliput contribution.
Harald Brüssow
wiley   +1 more source

АНТИГЕННАЯ АКТИВНОСТЬ ЭКСПЕРИМЕНТАЛЬНОЙ ИНАКТИВИРОВАННОЙ ЭМУЛЬCИОННОЙ ВАКЦИНЫ ПРОТИВ НЬЮКАСЛСКОЙ БОЛЕЗНИ И ПНЕВМОВИРУСНОЙ ИНФЕКЦИИ ПТИЦ

open access: yesВетеринарная патология, 2006
In the Russian Federation monovalent inactivated vaccines are developed and applied for specific prevention of avian pneumovirus infection and Newcastle disease.

doaj  

The effect of TIP on pneumovirus-induced pulmonary edema in mice. [PDF]

open access: yesPLoS ONE, 2014
BACKGROUND:Pulmonary edema plays a pivotal role in the pathophysiology of respiratory syncytial virus (RSV)-induced respiratory failure. In this study we determined whether treatment with TIP (AP301), a synthetic cyclic peptide that mimics the lectin ...
Elske van den Berg   +4 more
doaj   +1 more source

Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS‐CoV‐2 Infection in Older Adults During the JN.1 Lineage‐Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024

open access: yesInfluenza and Other Respiratory Viruses, Volume 18, Issue 11, November 2024.
ABSTRACT We estimated XBB.1.5 vaccine effectiveness (VE) against symptomatic SARS‐CoV‐2 infection among adults aged ≥ 65 years during the 2023/2024 JN.1 lineage‐predominant period in a European multi‐country test‐negative case–control study at primary care level. We estimated VE adjusted by study site, age, sex, chronic conditions and onset date.
Lore Merdrignac   +30 more
wiley   +1 more source

Synergy between avian pneumovirus andOrnithobacterium rhinotrachealein turkeys [PDF]

open access: yesAvian Pathology, 2005
The purpose of this study was to assess the possible synergism between Ornithobacterium rhinotracheale (ORT) and avian pneumovirus (APV), inoculated into turkeys via the natural route, for the reproduction of respiratory disease. Three-week-old specific pathogen free turkeys were inoculated oculonasally with either APV subtype A, ORT or both agents ...
Maja, Marien   +5 more
openaire   +2 more sources

CXCR3+ effector regulatory T cells associate with disease tolerance during lower respiratory pneumovirus infection

open access: yesImmunology, Volume 172, Issue 3, Page 500-515, July 2024.
High dimensional flow cytometry reveals unique subsets of regulatory T cells essential for preventing severe lung damage in neonatal mice experiencing acute lower respiratory infection. Abstract Lifestyle factors like poor maternal diet or antibiotic exposure disrupt early life microbiome assembly in infants, increasing the risk of severe lower ...
Ismail Sebina   +7 more
wiley   +1 more source

A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion protein

open access: yesFrontiers in Immunology, 2022
Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are two leading causes of severe respiratory infections in children, the elderly, and immunocompromised patients.
Jiachen Huang   +6 more
doaj   +1 more source

A Randomized, Double‐Blind, Placebo‐Controlled, Phase 1 Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Single Vaccination of Ad26.RSV.preF‐Based Regimen in Japanese Adults Aged 60 Years and Older

open access: yesInfluenza and Other Respiratory Viruses, Volume 18, Issue 6, June 2024.
ABSTRACT Background Respiratory syncytial virus (RSV) is increasingly recognized as a significant cause of lower respiratory tract disease (LRTD) in older adults. The Ad26.RSV.preF/RSV preF protein vaccine demonstrated protective efficacy against RSV related LRTD in a Phase 2b study in the United States.
Takashi Eto   +7 more
wiley   +1 more source

Genotypic Characterization of Human Respiratory Syncytial Viruses Detected in Mexico Between 2021 and 2024

open access: yesViruses
Human respiratory syncytial virus (HRSV) is a leading cause of severe respiratory infections among children, older adults, and immunocompromised individuals.
Nadia Martínez-Marrero   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy